Chromogranin a and pancreatic polypeptide are not suitable for the screening of pancreatic neuroendocrine tumors in MEN1 - a long-term follow-up study

CgA and PP are not helpful in diagnosing panNETs in MEN1. It is time to revise the surveillance protocols in practice.

Authors

Eeva Ryhänen (ORCID: https://orcid.org/0000-0001-5033-6432)
Susanna Majala (ORCID: https://orcid.org/0000-0002-2483-9148)
Niina Matikainen (ORCID: https://orcid.org/0000-0003-0041-1240)
Iiro Kostiainen (ORCID: https://orcid.org/0000-0002-2358-1181)
Camilla Schalin‐Jäntti (ORCID: https://orcid.org/0000-0002-2428-0161)
Saila Kauhanen (ORCID: https://orcid.org/0000-0002-7062-7162)
Jukka Schildt (ORCID: https://orcid.org/0000-0003-3773-8001)
Helka Parviainen

Institutions

University of Helsinki (FI)
Helsinki University Hospital (FI)
Turku University Hospital (FI)
Vaasa Central Hospital (FI)
Turku PET Centre (FI)
Hospital District of Helsinki and Uusimaa (FI)

Publication Details

Journal: Endocrine
Published: 2025-06-02
DOI: https://doi.org/10.1007/s12020-025-04291-y
Primary Topic: Neuroendocrine Tumor Research Advances
Type: article
Field-Weighted Citation Impact: 0.00

Funders

Helsingin Yliopisto
Helsingin ja Uudenmaan Sairaanhoitopiiri
Finska Läkaresällskapet

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Chromogranin a and pancreatic polypeptide are not suitable for the screening of pancreatic neuroendocrine tumors in MEN1 - a long-term follow-up study

Eeva Ryhänen, Susanna Majala, Niina Matikainen, Iiro Kostiainen et al.

Jun 2, 2025

Endocrine

Neuroendocrine Tumor Research Advances

article

Chromogranin a and pancreatic polypeptide are not suitable for the screening of pancreatic neuroendocrine tumors in MEN1 - a long-term follow-up study

Eeva Ryhänen, Susanna Majala, Niina Matikainen, Iiro Kostiainen, Camilla Schalin‐Jäntti, Saila Kauhanen, Jukka Schildt, Helka Parviainen

June 2, 2025article en

Abstract

CgA and PP are not helpful in diagnosing panNETs in MEN1. It is time to revise the surveillance protocols in practice.

EndocrineVol. 89(3)

University of Helsinki (FI), Helsinki University Hospital (FI), Turku University Hospital (FI), Vaasa Central Hospital (FI), Turku PET Centre (FI), Hospital District of Helsinki and Uusimaa (FI)

Helsingin Yliopisto, Helsingin ja Uudenmaan Sairaanhoitopiiri, Finska Läkaresällskapet

Good health and well-being

Openalex Percentile: Top 82%

Neuroendocrine Tumor Research Advances

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Chromogranin a and pancreatic polypeptide are not suitable for the screening of pancreatic neuroendocrine tumors in MEN1 - a long-term follow-up study — Eeva Ryhänen, Susanna Majala, et al. · Endocrine (2025) | TGRS Research Map | TGRS